Optometrists in South Kingstown, RI Accepting Medicare
3 Optometrists found. Showing 1 - 3
 Dr. Paul Zerbinopoulos, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 55 Village Square Dr, South Kingstown, RI 02879 Phone: 401-272-2020 Fax: 401-789-4113 |
Dr. Michael A Saccucci, MD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 55 Village Square Dr, South Kingstown, RI 02879 Phone: 401-272-2020 Fax: 401-789-4113 |
Saad Ahmed, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 55 Village Square Dr Ste 24, South Kingstown, RI 02879 Phone: 401-272-2029 Fax: 401-421-5979 |
News Archive
Neuromed discusses Exalgo NDA application with the FDA
Covidien today announced that on November 13, 2009, representatives of Neuromed discussed the pending New Drug Application (NDA) for the product candidate ExalgoTM (hydromorphone HCl extended release) tablets with staff from the United States Food and Drug Administration (FDA). Mallinckrodt Inc., a Covidien company, obtained the commercial rights to Exalgo in the United States from Neuromed Development Inc., a subsidiary of Neuromed Pharmaceuticals Ltd., in June 2009.
The Mount Sinai Hospital receives accreditation as geriatric emergency department
The Department of Emergency Medicine at The Mount Sinai Hospital is the first in New York State to be accredited as a geriatric emergency department by the American College of Emergency Physicians. Eight emergency departments in the nation received this accreditation, which is part of a nationwide effort to improve and standardize emergency care for elderly patients.
Study finds neuromelanin-sensitive MRI as potential biomarker for psychosis
Researchers have shown that a type of magnetic resonance imaging - called neuromelanin-sensitive MRI is a potential biomarker for psychosis.
HHS to offer $32 million to increase health care access for rural Americans
HHS Secretary Kathleen Sebelius announced today more than $32 million in FY 2010 funds to increase access to health care for Americans living in rural areas. The funds reach across seven programs administered by the Office of Rural Health Policy in HHS' Health Resources and Services Administration.
BioLight seeks FDA IND approval for subconjunctival Latanoprost controlled release insert Phase I/IIa study
BioLight Israeli Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announces that ViSci, its wholly owned subsidiary, has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to conduct a Phase I/IIa clinical study with its subconjunctival Latanoprost controlled release insert for the treatment of glaucoma.
› Verified 3 days ago
Physical Therapists
Occupational Therapists
Optometrists
Speech-Language Pathologists